Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics
Metrics: PDF 1184 views | HTML 2017 views | ?
Jie Qiao1,2,*, Cai-Yun Fang3,*, Sun-Xia Chen2, Xiao-Qing Wang2, Shu-Jian Cui4, Xiao-Hui Liu2, Ying-Hua Jiang2, Jie Wang2, Yang Zhang2, Peng-Yuan Yang1,2,3, Feng Liu1,2
1Department of Medical Systems Biology of School of Basic Medical Sciences, Shanghai, China
2Institutes of Biomedical Sciences Fudan University, Shanghai, China
3Department of Chemistry, Fudan University, Shanghai, China
4College of Bioscience and Biotechnology, Key Laboratory of Crop Genetics and Physiology of Jiangsu Province, Yangzhou University, Yangzhou, China
*These authors have contributed equally to this work
Feng Liu, e-mail: firstname.lastname@example.org
Peng-Yuan Yang, e-mail: email@example.com
Keywords: colorectal cancer, tumor microenvironment, fibroblast, proteomics, COL6A3
Received: February 10, 2015 Accepted: August 04, 2015 Published: August 18, 2015
Colorectal cancer (CRC) represents the third most common cancer in males and second in females worldwide. Here, we performed a quantitative 8-plex iTRAQ proteomics analysis of the secreted proteins from five colonic fibroblast cultures and three colon cancer epithelial cell lines. We identified 1114 proteins at 0% FDR, including 587 potential secreted proteins. We further recognized 116 fibroblast-enriched proteins which were significantly associated with cell movement, angiogenesis, proliferation and wound healing, and 44 epithelial cell-enriched proteins. By interrogation of Oncomine database, we found that 20 and 8 fibroblast-enriched proteins were up- and downregulated in CRC, respectively. Western blots confirmed the fibroblast-specific secretion of filamin C, COL6A3, COL4A1 and spondin-2. Upregulated mRNA and stroma expression of COL6A3 in CRC, which were revealed by Oncomine analyses and tissue-microarray-immunohistochemistry, indicated poor prognosis. COL6A3 expression was significantly associated with Dukes stage, T stage, stage, recurrence and smoking status. Circulating plasma COL6A3 in CRC patients was upregulated significantly comparing with healthy peoples. Receiver operating characteristic curve analysis revealed that COL6A3 has better predictive performance for CRC with an area under the curve of 0.885 and the best sensitivity/specificity of 92.9%/81.3%. Thus we demonstrated that COL6A3 was a potential diagnosis and prognosis marker of CRC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.